These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24919751)

  • 41. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.
    Ioannou K
    Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
    Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
    Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis.
    Yu Y; Bai F; Qin N; Liu W; Sun Q; Zhou Y; Yang J
    Nephron; 2018; 139(3):269-282. PubMed ID: 29539618
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationship of renal lesions with urinary protein excretion in patients with overt diabetic nephropathy].
    Okada T; Matsumoto H; Nakao T; Nagaoka Y; Yamada C; Shino T; Yoshino M; Hidaka H; Han MG; Ootani M; Shimizu T
    Nihon Jinzo Gakkai Shi; 1999 Aug; 41(5):475-85. PubMed ID: 10502941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy.
    Kim JH; Kim SS; Kim IJ; Lee MJ; Jeon YK; Kim BH; Song SH; Kim YK
    J Diabetes Complications; 2017 Feb; 31(2):395-399. PubMed ID: 27913013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stage-specific quantitative changes in renal and urinary proteome during the progression and development of streptozotocin-induced diabetic nephropathy in rats.
    Sharma V; Tikoo K
    Mol Cell Biochem; 2014 Mar; 388(1-2):95-111. PubMed ID: 24281856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute and chronic glomerular damage is associated with reduced CD133 expression in urinary extracellular vesicles.
    Dimuccio V; Peruzzi L; Brizzi MF; Cocchi E; Fop F; Boido A; Gili M; Gallo S; Biancone L; Camussi G; Bussolati B
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F486-F495. PubMed ID: 31869243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease.
    Miyata KN; Zhao XP; Chang SY; Liao MC; Lo CS; Chenier I; Ethier J; Cailhier JF; Lattouf JB; Troyanov S; Chiasson JL; Ingelfinger JR; Chan JSD; Zhang SL
    Transl Res; 2020 Mar; 217():1-10. PubMed ID: 31794697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal histologic changes in diabetes mellitus.
    Lane PH; Steffes MW; Mauer SM
    Semin Nephrol; 1990 May; 10(3):254-9. PubMed ID: 2190282
    [No Abstract]   [Full Text] [Related]  

  • 55. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Knowler WC; Rovin BH; Wu H; Klein JB; Mifflin TE; Feldman HI; Vasan RS; Kimmel PL; Kusek JW; Mauer M;
    Nephrol Dial Transplant; 2015 Apr; 30(4):599-606. PubMed ID: 25648911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tubular biomarkers to assess progression of diabetic nephropathy.
    Tramonti G; Kanwar YS
    Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients.
    Bolignano D; Lacquaniti A; Coppolino G; Donato V; Fazio MR; Nicocia G; Buemi M
    Kidney Blood Press Res; 2009; 32(2):91-8. PubMed ID: 19321980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Diabetic Nephropathy in Type 1 Diabetic Patients.
    Sisman P; Gul OO; Dirican M; Bal AS; Cander S; Erturk E
    Clin Lab; 2020 Jan; 66(1):. PubMed ID: 32013365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early urinary and plasma biomarkers for experimental diabetic nephropathy.
    Alter ML; Kretschmer A; Von Websky K; Tsuprykov O; Reichetzeder C; Simon A; Stasch JP; Hocher B
    Clin Lab; 2012; 58(7-8):659-71. PubMed ID: 22997966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary copper excretion in type 2 diabetic patients with nephropathy.
    Ito S; Fujita H; Narita T; Yaginuma T; Kawarada Y; Kawagoe M; Sugiyama T
    Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.